Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
November 17, 2017
VBL Therapeutics Prices 2.5 Million Ordinary Share Offering
TEL AVIV, Israel, Nov. 17, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
November 16, 2017
Spring Bank Pharmaceuticals Announces Positive Top-Line Results from the Second Cohort of Part A of the Phase 2 ACHIEVE Trial
HOPKINTON, Mass., Nov. 15, 2017 (GLOBE NEWSWIRE) --  Spring Bank Pharmaceuticals, Inc. (SBPH) today announced top-line results from the second cohort (50mg monotherapy) of Part ...
November 16, 2017
Arcturus Therapeutics Announces Completion of Merger with Alcobra Ltd. and Commences Trading on the Nasdaq Global Market
SAN DIEGO, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (Nasdaq:ARCT), a leading RNA medicines company, announced today the completion of its previously announced ...
November 16, 2017
MediWound Reports Third Quarter 2017 Financial Results
YAVNE, Israel, Nov. 16, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
November 16, 2017
Prothena Highlights Breadth of Novel Pipeline at R&D Day
DUBLIN, Ireland, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of ...
November 16, 2017
Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors
MORRISTOWN, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced the election ...
November 16, 2017
Vermillion Announces Publication of Foundational Health Economics Study
AUSTIN, Texas, Nov. 16, 2017 /PRNewswire/ -- Vermillion (VRML) announced today the acceptance and publication of a novel paper, "Economic Impact of Increased Utilization of ...
November 16, 2017
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock
SAN DIEGO, Nov. 16, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (MRTX) today announced the pricing of an underwritten public offering of 2,015,901 shares of its common ...
November 15, 2017
INNATE PHARMA : Third quarter 2017 report
Marseille, France, November 15, 2017, 7:00 AM CET -- Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces its revenues and cash ...
November 15, 2017
Foamix Reports Third Quarter 2017 Financial Results and Provides Business Update
REHOVOT, Israel, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX) (“Foamix Pharmaceuticals” or the “Company”), a clinical stage specialty pharmaceutical company focused on ...
November 15, 2017
BioTime Presents Updated OpRegen® Phase I/IIa Trial Data at AAO
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that ...
November 15, 2017
ADMA Biologics Further Enhances Intellectual Property Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Compositions
RAMSEY, N.J. and BOCA RATON, Fla., Nov. 15, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) is a vertically integrated biopharmaceutical and specialty immunoglobulin company ...
November 14, 2017
Aptose Reports Results for the Third Quarter Ended September 30, 2017
SAN DIEGO and TORONTO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
November 14, 2017
Molecular Templates, Inc. Reports Third Quarter 2017 Financial Results
AUSTIN, Texas, Nov. 14, 2017 (GLOBE NEWSWIRE) --  Molecular Templates, Inc. (MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s ...
November 14, 2017
Molecular Templates Strengthens Management Team with Appointment of Adam Cutler as Chief Financial Officer
Molecular Templates, Inc., (MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), today announced the appointment of ...
November 14, 2017
Windtree Therapeutics Reports Third Quarter 2017 Financial Results
WARRINGTON, Pa., Nov. 14, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported ...
November 14, 2017
Tel Aviv District Court Ordered MediWound to Purchase Approximately $1.5 Million of PolyHeal Shares; MediWound Weighing an Appeal
YAVNE, Israel, Nov. 13, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe ...
November 14, 2017
Recruitment completed in trial to evaluate the optimal dosing frequency for Zealand's long-acting GLP-2 analog glepaglutide
Copenhagen, Denmark, November 14, 2017 - Zealand Pharma announces that all subjects have been enrolled and dosed in a clinical trial with glepaglutide under an ...
November 14, 2017
UroGen Pharma Reports Third Quarter 2017 Financial Results and Recent Corporate Developments
RA’ANANA, Israel and NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
November 14, 2017
VBL Therapeutics Announces Third Quarter 2017 Financial Results
TEL AVIV, Israel, Nov. 14, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
Page 76 of 117